Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether seriesFrank Navas, Michael J Bishop, Deanna T Garrison, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 3, 2026
Real-world impact of lymph node assessment on adjuvant management in p53-abnormal endometrial carcinoma: a retrospective multicenter cohort from Central EuropePetra Bretova, Munachiso Iheme Ndukwe, Martina Romanova, et al.
Journal of Medicinal Chemistry|August 16, 2013
Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agentsAnna L Leivers, Matthew Tallant, J Brad Shotwell, et al.
Circulation|June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial InvestigatorsL Campeau, D B Hunninghake, G L Knatterud, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2001
2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amidesM J Bishop, J Berman, E C Bigham, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolinesMichael J Bishop, Kevin A Barvian, Judd Berman, et al.
Archives of Internal Medicine|April 8, 1996
Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderlyT J McLaughlin, S B Soumerai, D J Willison, et al.
Biodiversity Data Journal|July 6, 2019
Biodiversidata: An Open-Access Biodiversity Database for UruguayFlorencia Grattarola, Germán Botto, Inés da Rosa, et al.
Circulation|July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG InvestigatorsG L Knatterud, Y Rosenberg, L Campeau, et al.
Circulation|November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trialC W White, F L Gobel, L Campeau, et al.
Pageof 20